We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NFE icon
1351
New Fortress Energy
NFE
$24.1M
– –
-166
Closed -$254K –
NPO icon
1352
Enpro
NPO
$6.49B
– –
-1,272
Closed -$215K –
NVCR icon
1353
NovoCure
NVCR
$1.71B
– –
-13,623
Closed -$213K –
OGN icon
1354
Organon & Co
OGN
$3.62B
– –
-13,683
Closed -$257K –
OMF icon
1355
OneMain Financial
OMF
$6.44B
– –
-4,104
Closed -$210K –
PENN icon
1356
PENN Entertainment
PENN
$2.06B
– –
-17,749
Closed -$323K –
PSN icon
1357
Parsons
PSN
$4.76B
– –
-2,508
Closed -$208K –
QDEL icon
1358
QuidelOrtho
QDEL
$909M
– –
-5,974
Closed -$286K –
RIGL icon
1359
Rigel Pharmaceuticals
RIGL
$912M
– –
-1,012
Closed -$15K –
RKT icon
1360
Rocket Companies
RKT
$30.8B
– –
-11,332
Closed -$165K –
RPD icon
1361
Rapid7
RPD
$871M
– –
-4,515
Closed -$221K –
RUSHA icon
1362
Rush Enterprises Class A
RUSHA
$5.18B
– –
-6,033
Closed -$215K –
SPCE icon
1363
Virgin Galactic
SPCE
$405M
– –
-1,070
Closed -$31.7K –
SWTX icon
1364
DELISTED
SpringWorks Therapeutics
SWTX
– –
-4,164
Closed -$205K –
VCEL icon
1365
Vericel Corp
VCEL
$2.08B
– –
-4,848
Closed -$252K –
VIG icon
1366
Vanguard Dividend Appreciation ETF
VIG
$112B
– –
-11,650
Closed -$2.13M –
W icon
1367
Wayfair
W
$14.5B
– –
-5,765
Closed -$391K –
WDFC icon
1368
WD-40
WDFC
$2.72B
– –
-821
Closed -$208K –
WERN icon
1369
Werner Enterprises
WERN
$1.96B
– –
-9,121
Closed -$357K –
WKHS icon
1370
Workhorse Group
WKHS
$32.6M
– –
-4
Closed -$2.74K –
XSW icon
1371
State Street SPDR S&P Software & Services ETF
XSW
$476M
– –
-1,292
Closed -$202K –
JBTM icon
1372
JBT Marel
JBTM
$5.54B
– –
-1,931
Closed -$203K –
CTEV icon
1373
Claritev Corp
CTEV
$412M
– –
-566
Closed -$18.4K –
DM icon
1374
DELISTED
Desktop Metal, Inc.
DM
– –
-1,636
Closed -$14.4K –
NKLA icon
1375
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-1,483
Closed -$46.3K –

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.